Paradigm Spine inks a $75 million credit deal with PDL BioPharma it plans to use to refinance its existing credit and boost its U.S. commercial efforts.
Paradigm Spine said it inked a $75 million credit agreement with PDL BioPharma.
Paradigm Spine, which makes spinal implants, said it will take the 1st $50 million in at closing, with another $25 million in milestone-based payments on the table.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1f2ENJF
Cap comentari:
Publica un comentari a l'entrada